These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36382651)

  • 1. Operational Definitions of Treatment Response and Remission in Obsessive-Compulsive Disorder Capture Meaningful Improvements in Everyday Life.
    Mataix-Cols D; Andersson E; Aspvall K; Boberg J; Crowley JJ; de Schipper E; Fernández de la Cruz L; Flygare O; Ivanova E; Lenhard F; Lundström L; Rück C; Serlachius E; Cervin M
    Psychother Psychosom; 2022; 91(6):424-430. PubMed ID: 36382651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment response, symptom remission, and wellness in obsessive-compulsive disorder.
    Farris SG; McLean CP; Van Meter PE; Simpson HB; Foa EB
    J Clin Psychiatry; 2013 Jul; 74(7):685-90. PubMed ID: 23945445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response versus remission in obsessive-compulsive disorder.
    Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR
    J Clin Psychiatry; 2006 Feb; 67(2):269-76. PubMed ID: 16566623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long- term remission status in pediatric obsessive-compulsive disorder: Evaluating the predictive value of symptom severity after treatment.
    Jensen S; Mortensen EL; Skarphedinsson G; Højgaard DR; Hybel KA; Nissen JB; Tord Ivarsson ; Weidle B; Torp NC; Thomsen PH
    Psychiatry Res; 2022 Nov; 317():114906. PubMed ID: 36265194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.
    Brennan BP; Lee C; Elias JA; Crosby JM; Mathes BM; Andre MC; Gironda CM; Pope HG; Jenike MA; Fitzmaurice GM; Hudson JI
    J Psychiatr Res; 2014 Sep; 56():98-105. PubMed ID: 24909787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
    Skarphedinsson G; De Nadai AS; Storch EA; Lewin AB; Ivarsson T
    Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):47-55. PubMed ID: 27209422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirically Defining Treatment Response and Remission in Obsessive-Compulsive Disorder Using the Obsessive-Compulsive Inventory-Revised.
    Flygare O; Wallert J; Chen LL; Fernández de la Cruz L; Lundström L; Mataix-Cols D; Rück C; Andersson E
    Behav Ther; 2023 Jan; 54(1):43-50. PubMed ID: 36608976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of treatment on quality of life and functioning in OCD.
    Asnaani A; Kaczkurkin AN; Alpert E; McLean CP; Simpson HB; Foa EB
    Compr Psychiatry; 2017 Feb; 73():7-14. PubMed ID: 27838572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study.
    Andersson E; Ljótsson B; Hedman E; Kaldo V; Paxling B; Andersson G; Lindefors N; Rück C
    BMC Psychiatry; 2011 Aug; 11():125. PubMed ID: 21812991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congruence and discrepancy between self-rated and clinician-rated symptom severity on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) before and after a low-intensity intervention.
    Hauschildt M; Dar R; Schröder J; Moritz S
    Psychiatry Res; 2019 Mar; 273():595-602. PubMed ID: 30716599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure and response prevention versus stress management training for adults and adolescents with obsessive compulsive disorder: A randomized clinical trial.
    Himle JA; Grogan-Kaylor A; Hiller MA; Mannella KA; Norman LJ; Abelson JL; Prout A; Shunnarah AA; Becker HC; Russman Block SR; Taylor SF; Fitzgerald KD
    Behav Res Ther; 2024 Jan; 172():104458. PubMed ID: 38103359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of an interview-only version of the Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) in treatment-seeking youth with obsessive-compulsive disorder.
    Cervin M; Perrin S; Olsson E; Claesdotter-Knutsson E; Lindvall M
    Psychiatry Res; 2019 Jan; 271():171-177. PubMed ID: 30481695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder.
    Farhat LC; Vattimo EFQ; Ramakrishnan D; Levine JLS; Johnson JA; Artukoglu BB; Landeros-Weisenberger A; Asbahr FR; Cepeda SL; Comer JS; Fatori D; Franklin ME; Freeman JB; Geller DA; Grant PJ; Goodman WK; Heyman I; Ivarsson T; Lenhard F; Lewin AB; Li F; Merlo LJ; Mohsenabadi H; Peris TS; Piacentini J; Rosa-Alcázar AI; Rosa-Alcázar À; Rozenman M; Sapyta JJ; Serlachius E; Shabani MJ; Shavitt RG; Small BJ; Skarphedinsson G; Swedo SE; Thomsen PH; Turner C; Weidle B; Miguel EC; Storch EA; Mataix-Cols D; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2022 Apr; 61(4):495-507. PubMed ID: 34597773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of brief strategic therapy in treating obsessive-compulsive disorder: a case series.
    Proietti L; Aguglia A; Amerio A; Costanza A; Fesce F; Magnani L; Serafini G; Amore M
    Acta Biomed; 2022 Sep; 93(S1):e2022271. PubMed ID: 36134720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders.
    Bejerot S; Edman G; Anckarsäter H; Berglund G; Gillberg C; Hofvander B; Humble MB; Mörtberg E; Råstam M; Ståhlberg O; Frisén L
    Nord J Psychiatry; 2014 Nov; 68(8):549-59. PubMed ID: 24568661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Treatment Outcomes in Pediatric Obsessive-Compulsive Disorder Using a Self-Report Scale.
    McGuire JF; Geller DA; Murphy TK; Small BJ; Unger A; Wilhelm S; Storch EA
    Behav Ther; 2019 Mar; 50(2):314-324. PubMed ID: 30824248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining clinical severity in adults with obsessive-compulsive disorder.
    Storch EA; De Nadai AS; Conceição do Rosário M; Shavitt RG; Torres AR; Ferrão YA; Miguel EC; Lewin AB; Fontenelle LF
    Compr Psychiatry; 2015 Nov; 63():30-5. PubMed ID: 26555489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
    Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
    Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
    Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
    Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.